Pharmaceutical organizations have long relied on reach and visibility metrics as primary indicators of success. These metrics offer a sense of activity, but they fall short of capturing what truly matters. At the heart of the issue is a misalignment between visibility and value. High volumes of downloads, clicks, and content outputs can create the illusion of progress while masking a deeper question: is scientific engagement actually changing understanding, influencing clinical behavior, or improving patient outcomes?
Marie-Ange Noué, PhactMI President, Scientific Communication & Medical Information Senior Executive, frames this shift through the lens of “return on intelligence,” a concept that moves beyond measuring what was distributed to understanding what was learned and how those insights shaped decisions. “If we are not extracting and acting on this intelligence, which really is embedded in every single interaction, then we are leaving a significant amount of value on the table.”
From Output to Intelligence: A Structural Shift
Transforming scientific communications into a strategic function begins with redefining its purpose. Historically viewed as an output-driven operation centered on publications and materials, the function has evolved into an intelligence engine that informs broader medical strategy. Every interaction with healthcare professionals generates signals. These signals reveal education gaps, areas of confusion, and emerging scientific interests; when captured and analyzed systematically, they offer a continuous feedback loop.
Noué describes the turning point as the implementation of an AI-enabled omnichannel engagement ecosystem. This approach enabled teams to track and analyze engagement across channels, identify trends among stakeholders, and feed insights directly into field medical activities and content development. The result is a model that operates as a digital field force. It continuously learns and adapts, elevating scientific communications from a support role to a central driver of healthcare intelligence.
Decoding Engagement: What Data Reveals at Scale
At scale, engagement data begins to uncover patterns that traditional field models cannot detect. Noué’s work engaging more than 20,000 healthcare professionals annually revealed that interaction is far more nuanced than a single click or download. Understanding how healthcare professionals interact with content over time provides insight into sustained interest and knowledge acquisition. “We were able to understand engagement depth, not just whether someone clicked, but really how they interacted with the content over time.”
Equally important are topic-level demand signals, which highlight areas of growing scientific interest or uncertainty. Combined with behavioral segmentation across specialties, these insights allow organizations to tailor engagement strategies with greater precision. Perhaps most notably, the data confirms that medical engagement is non-linear and continuous. It unfolds across multiple channels and moments, driven by immediate clinical needs rather than scheduled interactions. This realization enables a shift from reactive communication to predictive engagement, where organizations anticipate needs before they are explicitly expressed.
Building the Bridge to Patient Outcomes
Despite progress, linking medical engagement directly to patient outcomes remains a work in progress. Noué acknowledges the gap, calling it “the million dollar question,” while outlining a clear path forward. Three foundational elements are required.
- First, integrated data ecosystems that connect engagement metrics with broader healthcare data.
- Second, alignment between medical engagement data and real-world evidence as well as clinical outcomes.
- Third, advanced analytics powered by AI capable of modeling how scientific exchange influences clinical decisions.
This evolution demands a shift in mindset. The question is no longer whether engagement occurred, but whether it made a measurable difference. AI-enabled models, particularly those focused on clinical adoption prediction, are beginning to make this connection tangible by linking scientific interactions to anticipated changes in practice.
Defining the Next Generation of Impact Metrics
Looking ahead, the definition of impact in medical affairs is undergoing a fundamental transformation. Success will be measured less by output and more by influence. Noué identifies three dimensions that will define this change:
- Scientific share of voice will reflect leadership in shaping the scientific conversation, not just presence within it.
- Depth and quality of engagement will capture how meaningfully healthcare professionals interact with information.
- Predictive influence will assess how effectively engagement drives clinical adoption and ultimately patient outcomes.
“We will ask not just did people open this email, but did this change scientific perception or behavior and how did that influence care,” Noué says. Organizations that embrace this model will be those that operationalize around return on intelligence, embedding insight generation and application into every layer of their strategy.
A Patient-Centered Future for Medical Affairs
The transformation of medical affairs reflects a growing commitment to ensuring that every interaction contributes to better healthcare delivery. Noué sees this as an ongoing journey, one that is beginning to reveal its impact. As measurement frameworks mature and AI capabilities expand, the connection between scientific engagement and patient outcomes will become increasingly visible. The implications extend beyond metrics. They signal a redefinition of purpose, where medical engagement is not just about disseminating knowledge, but about improving outcomes for every patient, everywhere.
Follow Marie-Ange Noué on LinkedIn or visit PhactMI for more insights.
